T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Delek US
DK
$4.18B
| $1.18M | ﹤0.01% |
29,210
+156
| +0.5% | +$5.71K |
|
|
KAMN
1777
DELISTED
Kaman Corp
KAMN
| $1.18M | ﹤0.01% |
18,516
-31,140
| -63% | -$1.87M |
|
1778
Alarm.com
ALRM
$2.74B
| $1.18M | ﹤0.01% |
21,984
+8,366
| +61% | +$516K |
|
|
DPLO
1779
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1.17M | ﹤0.01% |
192,456
+9,800
| +5% | +$52.1K |
|
1780
John Wiley & Sons Class A
WLY
$2.63B
| $1.16M | ﹤0.01% |
25,385
+7,718
| +44% | +$351K |
|
|
GCI
1781
DELISTED
Gannett Co., Inc
GCI
| $1.16M | ﹤0.01% |
142,582
+24,052
| +20% | +$214K |
|
1782
Korn Ferry
KFY
$4.36B
| $1.16M | ﹤0.01% |
28,983
+131
| +0.5% | +$5.96K |
|
1783
Deckers Outdoor
DECK
$12.7B
| $1.16M | ﹤0.01% |
39,552
+1,914
| +5% | +$49.8K |
|
|
ZEPP
1784
Zepp Health
ZEPP
$78.6M
| $1.16M | ﹤0.01% |
28,951
-14,092
| -33% | -$588K |
|
1785
Northwest Bancshares
NWBI
$2.31B
| $1.15M | ﹤0.01% |
65,512
+330
| +0.5% | +$5.66K |
|
|
AKRX
1786
DELISTED
Akorn Inc
AKRX
| $1.15M | ﹤0.01% |
223,975
+200
| +0.1% | +$770 |
|
1787
Cohu
COHU
$2.76B
| $1.15M | ﹤0.01% |
74,480
+149
| +0.2% | +$2.32K |
|
1788
Adeia
ADEA
$3.16B
| $1.15M | ﹤0.01% |
210,675
+30,135
| +17% | +$181K |
|
|
SGMO
1789
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.14M | ﹤0.01% |
106,068
+499
| +0.5% | +$5.31K |
|
|
SNBR
1790
DELISTED
Sleep Number
SNBR
| $1.14M | ﹤0.01% |
28,247
+63
| +0.2% | +$2.43K |
|
|
BPFH
1791
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $1.14M | ﹤0.01% |
94,389
+3,417
| +4% | +$38.4K |
|
1792
OneMain Financial
OMF
$7.51B
| $1.14M | ﹤0.01% |
33,614
-126
| -0.4% | -$4.11K |
|
1793
EnerSys
ENS
$7.2B
| $1.13M | ﹤0.01% |
16,539
-1,735
| -9% | -$113K |
|
|
NAV
1794
DELISTED
Navistar International
NAV
| $1.13M | ﹤0.01% |
32,828
-2,376
| -7% | -$78.9K |
|
|
LM
1795
DELISTED
Legg Mason, Inc.
LM
| $1.13M | ﹤0.01% |
29,531
+6,993
| +31% | +$242K |
|
1796
V2X
VVX
$2.55B
| $1.13M | ﹤0.01% |
27,733
+43
| +0.2% | +$1.58K |
|
1797
Hyatt Hotels
H
$16.9B
| $1.12M | ﹤0.01% |
14,732
-23
| -0.2% | -$1.74K |
|
1798
Halozyme
HALO
$11.4B
| $1.12M | ﹤0.01% |
65,290
+6,005
| +10% | +$96.9K |
|
|
EFII
1799
DELISTED
Electronics for Imaging
EFII
| $1.12M | ﹤0.01% |
30,402
+50
| +0.2% | +$1.78K |
|
1800
CBIZ
CBZ
$2.96B
| $1.12M | ﹤0.01% |
57,224
+1,800
| +3% | +$36.1K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.